Lillian Siu: Many exciting presentations on Developmental Therapeutics ESMO23.

Lillian Siu shared on X/Twitter:

“Many exciting presentations on Developmental Therapeutics ESMO23 – New ADCs, novel mutant specific inhibitors and more. See you in Madrid Oct 20-24 at ⁦ESMO.”

For the video attached to the post click here.
Source: Lillian Siu/Twitter

Lillian Siu is a Professor of Medicine at the University of Toronto (Canada), senior medical oncologist, Director of the Phase I Program, Co-Director of the Bras and Family Drug Development Program and the Clinical Lead for the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre. She holds the BMO Chair in Precision Genomics (2016-2026).  Dr. Siu served on the Board of Directors for the American Society of Clinical Oncology (ASCO), was a member of the Nomination Committee for the American Association for Cancer Research (AACR) (2014-2016), and currently serves on the AACR Board of Directors. She is a scientific editor for Cancer Discovery and is on the editorial board for JAMA Oncology.